{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:22:40Z","timestamp":1787062960282,"version":"build-2736575974"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"crossref","award":["DK112984, DK121846"],"award-info":[{"award-number":["DK112984, DK121846"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"crossref","award":["1I01BX003698, 1I01BX005300"],"award-info":[{"award-number":["1I01BX003698, 1I01BX005300"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"crossref","award":["5IK2BX005380"],"award-info":[{"award-number":["5IK2BX005380"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100015502","name":"Dialysis Clinics","doi-asserted-by":"crossref","award":["DCI"],"award-info":[{"award-number":["DCI"]}],"id":[{"id":"10.13039\/100015502","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100015502","name":"Dialysis Clinics","doi-asserted-by":"crossref","award":["DCI"],"award-info":[{"award-number":["DCI"]}],"id":[{"id":"10.13039\/100015502","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["JASN"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>Detrimental effects of Kr\u00fcppel-like factor 4 knockdown in podocytes were eliminated with the inhibition of signal transducer and activator of transcription 3 (STAT3) signaling specifically in podocytes.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Human kidney biopsies with renal vasculitis demonstrated a glomerular enrichment of STAT3 downstream genes, which negatively correlated with eGFR.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Deconvolution of the bulk RNA-seq from Nephrotic Syndrome Study Network showed an enrichment of STAT3 downstream genes in podocytes as compared with other cell clusters.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Podocyte loss and parietal epithelial cell activation are features of subtypes of glomerulonephritis and FSGS. We recently reported that the podocyte-specific loss of\n                      <jats:italic toggle=\"yes\">Kr\u00fcppel-like factor 4<\/jats:italic>\n                      (\n                      <jats:italic toggle=\"yes\">Klf4<\/jats:italic>\n                      <jats:sup>\u0394Pod<\/jats:sup>\n                      ) triggers dysregulated glomerular signal transducer and activator of transcription 3 (STAT3) activation, podocyte loss with parietal epithelial cell activation and proliferation, leading to FSGS. Although pharmacologic systemic STAT3 inhibition attenuated this phenotype, it remains unclear whether the detrimental effects of\n                      <jats:italic toggle=\"yes\">Klf4<\/jats:italic>\n                      loss are primarily a result of dysregulated STAT3 activation intrinsically in podocytes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Mice with the concurrent and conditional knockdown of\n                      <jats:italic toggle=\"yes\">Stat3<\/jats:italic>\n                      and\n                      <jats:italic toggle=\"yes\">Klf4<\/jats:italic>\n                      (\n                      <jats:italic toggle=\"yes\">Klf4<\/jats:italic>\n                      <jats:sup>\u0394Pod<\/jats:sup>\n                      <jats:italic toggle=\"yes\">Stat3<\/jats:italic>\n                      <jats:sup>\u0394Pod<\/jats:sup>\n                      ) were generated and characterized. Expression arrays from kidney biopsies with various types of glomerular diseases, deposited in Nephroseq, were interrogated for glomerular expression of genes downstream of STAT3 signaling. Cell-specific modulation of STAT3 genes was determined using  single-cell RNA sequencing\u2013based proportional cell type deconvolution of bulk RNA-seq obtained from the Nephrotic Syndrome Study Network (NEPTUNE) FSGS and healthy controls.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      <jats:italic toggle=\"yes\">Klf4<\/jats:italic>\n                      <jats:sup>\u0394Pod<\/jats:sup>\n                      <jats:italic toggle=\"yes\">Stat3<\/jats:italic>\n                      <jats:sup>\u0394Pod<\/jats:sup>\n                      mice demonstrated no significant podocyte loss, parietal epithelial cell activation and proliferation, FSGS lesions, albuminuria, kidney dysfunction, and tubulointerstitial fibrosis and inflammation compared with the\n                      <jats:italic toggle=\"yes\">Klf4<\/jats:italic>\n                      <jats:sup>\u0394Pod<\/jats:sup>\n                      mice.\n                      <jats:italic toggle=\"yes\">Klf4<\/jats:italic>\n                      <jats:sup>\u0394Pod<\/jats:sup>\n                      <jats:italic toggle=\"yes\">Stat3<\/jats:italic>\n                      <jats:sup>\u0394Pod<\/jats:sup>\n                      mice also exhibited less glomerular myofibroblasts (+\n                      <jats:italic toggle=\"yes\">\u03b1<\/jats:italic>\n                      -smooth muscle actin) as compared with\n                      <jats:italic toggle=\"yes\">Klf4<\/jats:italic>\n                      <jats:sup>\u0394Pod<\/jats:sup>\n                      mice. Overall survival was restored in\n                      <jats:italic toggle=\"yes\">Klf4<\/jats:italic>\n                      <jats:sup>\u0394Pod<\/jats:sup>\n                      <jats:italic toggle=\"yes\">Stat3<\/jats:italic>\n                      <jats:sup>\u0394Pod<\/jats:sup>\n                      mice as compared with\n                      <jats:italic toggle=\"yes\">Klf4<\/jats:italic>\n                      <jats:sup>\u0394Pod<\/jats:sup>\n                      mice. Interrogation of expression arrays from human kidney biopsies with renal vasculitis demonstrated a glomerular enrichment of genes involved in canonical STAT3 signaling as compared with healthy controls, which negatively correlated with eGFR. Deconvolution of the bulk RNA-seq data from NEPTUNE showed an enrichment of these STAT3 genes in podocytes as compared with other glomerular cell clusters.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Collectively, these data demonstrate that inhibiting podocyte-specific STAT3 signaling was sufficient to counter the detrimental effects of\n                      <jats:italic toggle=\"yes\">Klf4<\/jats:italic>\n                      loss in podocytes and prevented albuminuria, accelerated podocyte loss, activation and proliferation of parietal epithelial cells, FSGS lesions, and kidney failure.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1681\/asn.0000000841","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T16:02:03Z","timestamp":1756483323000},"page":"490-503","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Podocyte-Specific Deletion of STAT3 in Kr\u00fcppel-Like Factor 4\u2013Related Experimental Podocytopathy"],"prefix":"10.1681","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-3705-3221","authenticated-orcid":false,"given":"Yogesh","family":"Gowthaman","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Stony Brook University, Stony Brook, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsea C.","family":"Estrada","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Stony Brook University, Stony Brook, New York"},{"name":"Division of Nephrology, Department of Medicine, Northport Veterans Affairs Medical Center, Northport, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0417-4588","authenticated-orcid":false,"given":"Joseph","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Stony Brook University, Stony Brook, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5437-3433","authenticated-orcid":false,"given":"Yiqing","family":"Guo","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Stony Brook University, Stony Brook, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8537-8835","authenticated-orcid":false,"given":"Robert","family":"Bronstein","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Stony Brook University, Stony Brook, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3866-3120","authenticated-orcid":false,"given":"David J.","family":"Salant","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1502-2849","authenticated-orcid":false,"given":"John C.","family":"He","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7760-6965","authenticated-orcid":false,"given":"Vivette D.","family":"D\u2019Agati","sequence":"additional","affiliation":[{"name":"Department of Pathology and Cell Biology, Columbia University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6324-7807","authenticated-orcid":false,"given":"Sandeep K.","family":"Mallipattu","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Stony Brook University, Stony Brook, New York"},{"name":"Division of Nephrology, Department of Medicine, Northport Veterans Affairs Medical Center, Northport, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,9,2]]},"reference":[{"issue":"2","key":"B1-20260428","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1053\/j.ajkd.2003.10.024","article-title":"Pathologic classification of focal segmental glomerulosclerosis: a working proposal","volume":"43","author":"D'Agati","year":"2004","journal-title":"Am J Kidney Dis."},{"issue":"2","key":"B2-20260428","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1053\/j.ajkd.2003.06.005","article-title":"An overlapping etiology of rapidly progressive glomerulonephritis","volume":"43","author":"Markowitz","year":"2004","journal-title":"Am J Kidney Dis."},{"issue":"4","key":"B3-20260428","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1097\/01.ASN.0000120559.09189.82","article-title":"The parietal epithelial cell: a key player in the pathogenesis of focal segmental glomerulosclerosis in Thy-1.1 transgenic mice","volume":"15","author":"Smeets","year":"2004","journal-title":"J Am Soc Nephrol."},{"issue":"12","key":"B4-20260428","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1681\/ASN.2009010122","article-title":"Tracing the origin of glomerular extracapillary lesions from parietal epithelial cells","volume":"20","author":"Smeets","year":"2009","journal-title":"J Am Soc Nephrol."},{"issue":"1","key":"B5-20260428","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12882-024-03532-y","article-title":"Clinicopathological characteristics and predictors of outcome of rapidly progressive glomerulonephritis: a retrospective study","volume":"25","author":"Mohamed","year":"2024","journal-title":"BMC Nephrol."},{"issue":"1","key":"B6-20260428","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/MNH.0000000000000079","article-title":"JAK inhibition and progressive kidney disease","volume":"24","author":"Brosius","year":"2015","journal-title":"Curr Opin Nephrol Hypertens."},{"issue":"5","key":"B7-20260428","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/ki.2013.197","article-title":"Podocyte-specific deletion of signal transducer and activator of transcription 3 attenuates nephrotoxic serum-induced glomerulonephritis","volume":"84","author":"Dai","year":"2013","journal-title":"Kidney Int."},{"issue":"10","key":"B8-20260428","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1681\/ASN.2008080879","article-title":"Reduction of Stat3 activity attenuates HIV-induced kidney injury","volume":"20","author":"Feng","year":"2009","journal-title":"J Am Soc Nephrol."},{"issue":"7","key":"B9-20260428","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1097\/QAD.0b013e32835f1ea1","article-title":"Deletion of podocyte STAT3 mitigates the entire spectrum of HIV-1-associated nephropathy","volume":"27","author":"Gu","year":"2013","journal-title":"AIDS."},{"issue":"2","key":"B10-20260428","doi-asserted-by":"crossref","first-page":"F259","DOI":"10.1152\/ajprenal.00550.2016","article-title":"The critical role of Kruppel-like factors in kidney disease","volume":"312","author":"Mallipattu","year":"2017","journal-title":"Am J Physiol Renal Physiol."},{"issue":"33","key":"B11-20260428","doi-asserted-by":"crossref","first-page":"20009","DOI":"10.1074\/jbc.271.33.20009","article-title":"Identification and characterization of a gene encoding a gut-enriched Kruppel-like factor expressed during growth arrest","volume":"271","author":"Shields","year":"1996","journal-title":"J Biol Chem."},{"issue":"12","key":"B12-20260428","doi-asserted-by":"crossref","first-page":"e98214","DOI":"10.1172\/jci.insight.98214","article-title":"Kruppel-like factor 4 is a negative regulator of STAT3-induced glomerular epithelial cell proliferation","volume":"3","author":"Estrada","year":"2018","journal-title":"JCI Insight."},{"issue":"36","key":"B13-20260428","doi-asserted-by":"crossref","first-page":"eabg6600","DOI":"10.1126\/sciadv.abg6600","article-title":"Podocyte-specific KLF4 is required to maintain parietal epithelial cell quiescence in the kidney","volume":"7","author":"Pace","year":"2021","journal-title":"Sci Adv."},{"issue":"11","key":"B14-20260428","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1101\/gr.155697.113","article-title":"Defining cell-type specificity at the transcriptional level in human disease","volume":"23","author":"Ju","year":"2013","journal-title":"Genome Res."},{"issue":"6","key":"B15-20260428","doi-asserted-by":"crossref","first-page":"bbac430","DOI":"10.1093\/bib\/bbac430","article-title":"MuSiC2: cell-type deconvolution for multi-condition bulk RNA-seq data","volume":"23","author":"Fan","year":"2022","journal-title":"Brief Bioinform."},{"issue":"3","key":"B16-20260428","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.kint.2022.10.023","article-title":"Precision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosis","volume":"103","author":"Mariani","year":"2023","journal-title":"Kidney Int."},{"issue":"1","key":"B17-20260428","doi-asserted-by":"crossref","first-page":"6497","DOI":"10.1038\/s41467-022-34255-z","article-title":"Defining cellular complexity in human autosomal dominant polycystic kidney disease by multimodal single cell analysis","volume":"13","author":"Muto","year":"2022","journal-title":"Nat Commun."},{"issue":"12","key":"B18-20260428","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1681\/ASN.2020050572","article-title":"Synaptopodin is dispensable for normal podocyte homeostasis but is protective in the context of acute podocyte injury","volume":"31","author":"Ning","year":"2020","journal-title":"J Am Soc Nephrol."},{"issue":"3","key":"B19-20260428","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.kint.2017.09.020","article-title":"CD44 is required for the pathogenesis of experimental crescentic glomerulonephritis and collapsing focal segmental glomerulosclerosis","volume":"93","author":"Eymael","year":"2018","journal-title":"Kidney Int."},{"issue":"4","key":"B20-20260428","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/labinvest.2011.199","article-title":"SSeCKS sequesters cyclin D1 in glomerular parietal epithelial cells and influences proliferative injury in the glomerulus","volume":"92","author":"Burnworth","year":"2012","journal-title":"Lab Invest."},{"issue":"23","key":"B21-20260428","doi-asserted-by":"crossref","first-page":"e2024414118","DOI":"10.1073\/pnas.2024414118","article-title":"Kruppel-like factor 6-mediated loss of BCAA catabolism contributes to kidney injury in mice and humans","volume":"118","author":"Piret","year":"2021","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"1","key":"B22-20260428","doi-asserted-by":"crossref","first-page":"6894","DOI":"10.1038\/s41598-020-63749-3","article-title":"Usefulness of morphometric image analysis with Sirius Red to assess interstitial fibrosis after renal transplantation from uncontrolled circulatory death donors","volume":"10","author":"Dao","year":"2020","journal-title":"Sci Rep."},{"issue":"12","key":"B23-20260428","doi-asserted-by":"crossref","first-page":"e50745","DOI":"10.1371\/journal.pone.0050745","article-title":"Upregulated expression of integrin \u03b11 in mesangial cells and integrin \u03b13 and vimentin in podocytes of Col4a3-null (Alport) mice","volume":"7","author":"Steenhard","year":"2012","journal-title":"PLoS One."},{"issue":"1","key":"B24-20260428","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000528727","article-title":"Expression of wilms' tumor 1 antigen, vimentin, and corticotropin-releasing factor in the human kidney with focal segmental glomerulosclerosis and effect of oxidative stress on these markers in HEK 293 cells","volume":"48","author":"Csurgyok","year":"2023","journal-title":"Kidney Blood Press Res."},{"issue":"5","key":"B25-20260428","first-page":"17","article-title":"[The role of smooth muscle alpha-actin in development of renal fibrosis in patients with chronic glomerulonephritis]","volume":"78","author":"Chebotareva","year":"2006","journal-title":"Ter Arkh."},{"issue":"6","key":"B26-20260428","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1002\/eji.201747138","article-title":"CCR2-dependent Gr1(high) monocytes promote kidney injury in Shiga toxin-induced hemolytic uremic syndrome in mice","volume":"48","author":"Pohl","year":"2018","journal-title":"Eur J Immunol."},{"key":"B27-20260428","doi-asserted-by":"crossref","first-page":"681748","DOI":"10.3389\/fimmu.2021.681748","article-title":"Macrophage heterogeneity in kidney injury and fibrosis","volume":"12","author":"Wen","year":"2021","journal-title":"Front Immunol."},{"issue":"5","key":"B28-20260428","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1007\/s10067-019-04467-8","article-title":"Upregulated expression of STAT3\/IL-17 in patients with systemic lupus erythematosus","volume":"38","author":"Chen","year":"2019","journal-title":"Clin Rheumatol."},{"key":"B29-20260428","doi-asserted-by":"crossref","first-page":"174121","DOI":"10.1016\/j.ejphar.2021.174121","article-title":"JAK\/STAT pathway promotes the progression of diabetic kidney disease via autophagy in podocytes","volume":"902","author":"Chen","year":"2021","journal-title":"Eur J Pharmacol."},{"issue":"5","key":"B30-20260428","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1172\/JCI200421004","article-title":"Nef stimulates proliferation of glomerular podocytes through activation of Src-dependent Stat3 and MAPK1,2 pathways","volume":"114","author":"He","year":"2004","journal-title":"J Clin Invest."},{"issue":"6","key":"B31-20260428","first-page":"351","article-title":"Renal protective effect of boeravinone B against diabetic nephropathy rats via inhibition of the inflammatory and JAK2\/STAT3 signalling pathway","volume":"26","author":"Wen","year":"2024","journal-title":"Cell J."},{"issue":"5","key":"B32-20260428","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1681\/ASN.0000000000000104","article-title":"Podocyte-parietal epithelial cell interdependence in glomerular development and disease","volume":"34","author":"Bronstein","year":"2023","journal-title":"J Am Soc Nephrol."},{"issue":"1","key":"B33-20260428","doi-asserted-by":"crossref","first-page":"8038","DOI":"10.1038\/s41467-024-52306-5","article-title":"Podocyte-specific KLF6 primes proximal tubule CaMK1D signaling to attenuate diabetic kidney disease","volume":"15","author":"Gujarati","year":"2024","journal-title":"Nat Commun."},{"issue":"3","key":"B34-20260428","doi-asserted-by":"crossref","first-page":"F741","DOI":"10.1152\/ajprenal.00414.2019","article-title":"Biphasic MIF and SDF1 expression during podocyte injury promote CD44-mediated glomerular parietal cell migration in focal segmental glomerulosclerosis","volume":"318","author":"Ito","year":"2020","journal-title":"Am J Physiol Renal Physiol."},{"issue":"10","key":"B35-20260428","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1681\/ASN.2018030324","article-title":"Podocyte-specific induction of kruppel-like factor 15 restores differentiation markers and attenuates kidney injury in proteinuric kidney disease","volume":"29","author":"Guo","year":"2018","journal-title":"J Am Soc Nephrol."},{"issue":"4","key":"B36-20260428","first-page":"3240","article-title":"Kruppel-like factor 4 ameliorates diabetic kidney disease by activating autophagy via the mTOR pathway","volume":"20","author":"Gong","year":"2019","journal-title":"Mol Med Rep."},{"issue":"6","key":"B37-20260428","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1172\/JCI69557","article-title":"KLF4-dependent epigenetic remodeling modulates podocyte phenotypes and attenuates proteinuria","volume":"124","author":"Hayashi","year":"2014","journal-title":"J Clin Invest."},{"issue":"8","key":"B38-20260428","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1073\/pnas.94.8.3801","article-title":"Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality","volume":"94","author":"Takeda","year":"1997","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"10","key":"B39-20260428","doi-asserted-by":"crossref","first-page":"110473","DOI":"10.1016\/j.celrep.2022.110473","article-title":"Deletion of STAT3 from Foxd1 cell population protects mice from kidney fibrosis by inhibiting pericytes trans-differentiation and migration","volume":"38","author":"Ajay","year":"2022","journal-title":"Cell Rep."},{"issue":"12","key":"B40-20260428","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1681\/ASN.2015091014","article-title":"Stat3 controls tubulointerstitial communication during CKD","volume":"27","author":"Bienaime","year":"2016","journal-title":"J Am Soc Nephrol."}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1681\/ASN.0000000841","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:49:28Z","timestamp":1786132168000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1681\/ASN.0000000841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.0000000841","relation":{},"ISSN":["1046-6673","1533-3450"],"issn-type":[{"value":"1046-6673","type":"print"},{"value":"1533-3450","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,2]]},"assertion":[{"value":"2025-04-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}